| Trial ID: | L7130 |
| Source ID: | NCT02263677
|
| Associated Drug: |
Sitagliptin
|
| Title: |
Evaluation of the DPP-4 Inhibitor Sitagliptin in the Treatment of Non-Alcoholic Fatty Liver Disease Using MRI
|
| Acronym: |
|
| Status: |
WITHDRAWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes|Non-alcoholic Fatty Liver Disease
|
| Interventions: |
DRUG: Sitagliptin
|
| Outcome Measures: |
Primary: Change in Liver steatosis, Steatosis measured by Magnetic Resonance Spectroscopy, baseline and Six months |
|
| Sponsor/Collaborators: |
Sponsor: University of Missouri-Columbia
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
0
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2014-03
|
| Completion Date: |
2016-01
|
| Results First Posted: |
|
| Last Update Posted: |
2016-10-05
|
| Locations: |
University of Missouri-Columbia: Diabetes Center, Columbia, Missouri, 65212, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT02263677
|
